https://www.marketscreener.com/quote/stock/ALECTOR-INC-54379343/news/Alector-Announces-First-Patient-Dosed-in-PROGRESS-AD-Phase-2-Clinical-Trial-of-AL101-GSK4527226-in-P-45912548/?utm_source=telegram&utm_medium=social&utm_campaign=share